Pricing Log in Create free account

Fractyl Health, Inc. (GUTS) vs Tvardi Therapeutics, Inc. (TVRD)

Fractyl Health, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Fractyl Health, Inc. and Tvardi Therapeutics, Inc. are of similar size ($11.9M and $11.5M). Fractyl Health, Inc. grew revenue faster over the last twelve months: −22.5% against −55.3%. Across the 12 metrics below, Fractyl Health, Inc. leads on 6 and Tvardi Therapeutics, Inc. on 6.

Valuation

Metric GUTS TVRD Biotechnology median
P/E n/m n/m 10.60
P/S 133.58 1.20 9.40
P/B n/m 1.09 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.05 n/m 0.66
EV/Sales (45.93) 6.98 9.02
Earnings yield (1,123.85%) (287.63%) (32.88%)
Free cash flow yield (668.02%) (309.54%) (23.13%)

Profitability

Metric GUTS TVRD Biotechnology median
Gross margin 46.24% 146.85% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 1,063.04% (126.19%) (51.96%)
Return on assets (146.75%) (85.08%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GUTS TVRD Biotechnology median
Revenue growth (TTM) (22.50%) (55.30%) 6.76%
EPS growth (last fiscal year) (14.81%) 71.45% 29.88%
Revenue growth, 5-year CAGR — (18.53%) 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric GUTS TVRD Biotechnology median
Debt to equity (18.29) 0.00 0.00
Current ratio 3.15 1.87 4.97
Net debt to EBITDA 0.53 1.15 1.01

Dividend

Metric GUTS TVRD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GUTS TVRD Biotechnology median
Market cap 11.88m 11.53m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack